Showing results (261-270 of 302) with videos related to

Sort By:
Pageof 31
Molecular Psychiatry|March 3, 2010
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugsD E Adkins, K Aberg, J L McClay, et al.
Clinical Breast Cancer|December 21, 2019
Long-Term Outcomes of Multiple-Wire Localizations for More Extensive Breast Cancer: Multiple-Wire Excision Does Not Increase Recurrence, Unplanned Imaging, or BiopsiesCarson L Brown, Maureen P McEvoy, Barbara L Smith, et al.
The Lancet. Psychiatry|July 3, 2017
Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trialKaren E Anderson, David Stamler, Mat D Davis, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2008
Extrapyramidal side-effects of antipsychotics in a randomised trialDel D Miller, Stanley N Caroff, Sonia M Davis, et al.
The New England Journal of Medicine|September 21, 2005
Effectiveness of antipsychotic drugs in patients with chronic schizophreniaJeffrey A Lieberman, T Scott Stroup, Joseph P McEvoy, et al.
The Journal of Nervous and Mental Disease|March 15, 2006
Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
Schizophrenia Research|January 15, 2008
The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE studyMarvin S Swartz, H Ryan Wagner, Jeffrey W Swanson, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 6, 2005
Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophreniaDaniel J Müller, Vincenzo De Luca, Tricia Sicard, et al.
The American Journal of Psychiatry|April 6, 2006
Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatmentJoseph P McEvoy, Jeffrey A Lieberman, T Scott Stroup, et al.
Schizophrenia Research|August 5, 2006
Olanzapine and haloperidol in first episode psychosis: two-year dataA I Green, J A Lieberman, R M Hamer, et al.
Pageof 31